Bixiye
QP20R1-20 Update: Medical Drug Update for Teprotumumab (Tepezza)
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2371 - 2380 ee natiijooyinka 3563
Bixiye
QP46-20 Validation of National Drug Codes Submitted with Medical Drug Claims
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
QP45-20 Preventive Care Provided Via Telehealth
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
QP43-20 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Valrox)
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
QP44-20 Non-Covered Medicare Services and Organization Determination Reminder for Platinum Blue and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 13, 2020
Bixiye
P29-20 Sequestration Suspension for Medicare Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Bixiye
P31-20 2020 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Bixiye
P38-20 Non-Emergency Medical Transportation Fee Schedule Update
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Bixiye
P26-20 Minnesota Senior Health Options (MSHO) Model of Care Training Requirements
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Bixiye
P25-20 Children’s Therapeutic Services and Supports (CTSS) Prior Authorization Requirement
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023